No concerns are anticipated on the safety and efficacy of COVID-19 vaccines on people with underlying liver or gastrointestinal disease, according to an updated advice from the Gastroenterological Society of Australia (GESA). This includes people with immunocompromised conditions or who are on immunosuppressants.
Find out more about the planned COVID-19 vaccine rollout in South Australia.
Support booklet and appendix from EC Australia in partnership with Hepatitis SA for General Practitioners treating people with hepatitis C.
Read the latest issue online now — Eureka Prize | Nobel Prize | Hep B Treatment | COVID Etiquette | Pink Ladies | Urine Test for Fibrosis? | What's On? / CNP Info | Hep C Elimination | In Our Library
Professor Dore led the first international hepatitis C therapy trials to include study populations of people who inject drugs.
In the current COVID situation, until there are effective vaccines or treatments, the only effective safeguard we have is being careful in how we interact with others.
There are many reasons why we tell stories. We tell them to be heard, to pass on wisdom, to gain perspective and to document information that may be useful later.
Understanding hepatitis A, B and C may not be quite as simple as ABC, but a session with Hepatitis SA's highly skilled educators will certainly help you get there.
In this information age it is ironic that credible, reliable information can sometimes be hard to find in the tsunami of results from online searches.
Guide to South Australian community pharmacies which dispense the new hepatitis C medicines.
Hepatitis is inflammation of the liver. It can be brought on by alcohol, drugs, viruses and other toxins. Viral hepatitis refers to hepatitis resulting from infection of the liver by the hepatitis A, B, C, D or E viruses - hepatitis A, B and C being the most common. These viruses all produce similar symptoms, but differ in modes of transmission and long-term effects on health.
Hepatitis B is spread through blood, sexual fluids and from mother to child during birth. If left unmanaged, it can lead to cirrhosis and liver cancer.
An estimated 257 million people are living with chronic hepatitis B worldwide - 226,000 of them in Australia.
Hepatitis C is transmitted via blood-to-bloodstream contact. Untreated, hepatitis C can lead to cirrhosis and serious liver disease. Effective treatments are available.
World-wide, there are an estimated 71 million people living with chronic hepatitis C - 114,000 of them in Australia.
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C. This includes people with hepatitis B or C, their family and friends, and professionals who support them. We also provide hepatitis C and clean needle program (CNP) peer education and support services, and operate a CNP secondary site.
